Clinical evaluation of blood glucose variability with continuous intravenous measurement in ICU patients (GLIC-study)

Clinical evaluation of blood glucose variability with continuous intravenous measurement in ICU patients (GLIC-study) - GLIC3.0

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON40555

Enrollment

Registered

2013-08-30

Start date

2013-09-23

Completion date

Unknown

Last updated

2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hyperglycemia stress diabetes

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Age of 18 years or older, surgical or medical patients admitted to the ICU or MCU with a planned stay at the ICU of at least 8 hours.

Exclusion criteria

Exclusion criteria: No informed consent Contra-indication or allergy for heparin Glucose in targetrange (4.4-6.1 mmol/L) Pregnancy Difficult to place a peripheral intravenous catheter

Design outcomes

Primary

Measure	Time frame
Primary endpoint in this study is to evaluate the added value of continuous intravenous measurement of blood glucose variability after cardiothoracic surgery and during treatment at respectively, the Intensive Care Unit and Medium Care Unit. Study parameters in this study are calculation of: - mean glucose (mmol/L) (per patient, per subgroup, total average) - percentage of patients observed experiencing severe hyperglycemia (glucose > 10.0 mmol/L), - percentage of mild hyperglycemia (glucose 6.1-10.0 mmol/L) - percentage of mild hypoglycaemia (2.2-3.9 mmol/L) - percentage of severe hypoglycaemia (	—

Measure

Time frame

Primary endpoint in this study is to evaluate the added value of continuous intravenous measurement of blood glucose variability after cardiothoracic surgery and during treatment at respectively, the Intensive Care Unit and Medium Care Unit. Study parameters in this study are calculation of: - mean glucose (mmol/L) (per patient, per subgroup, total average) - percentage of patients observed experiencing severe hyperglycemia (glucose > 10.0 mmol/L), - percentage of mild hyperglycemia (glucose 6.1-10.0 mmol/L) - percentage of mild hypoglycaemia (2.2-3.9 mmol/L) - percentage of severe hypoglycaemia (

—

Secondary

Measure	Time frame
-	—

Countries

Netherlands

Outcome results